Search - tctmd.com

Displaying 941 - 960 of 1172

Sort: Relevancy | Date

Presentation TCT 2015

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

Presenter: Spencer B. King III, Jagat Narula, James B. Hermiller Jr

October 12, 2015

Presentation TCT 2015

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

Presenter: Michael J. Lim, Molly Szerlip

October 12, 2015

Presentation TCT 2015

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

Presenter: Morton J. Kern, Jan J. Piek, Justin E. Davies

October 12, 2015

Presentation TCT 2015

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

Presentation TCT 2015

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Mao Chen

October 11, 2015

Presentation TCT 2015

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Presenter: Run-Lin Gao, Martin B. Leon, Bo Xu, Yongjian Wu

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 4: Aortic Stenosis + Mitral Regurgitation

Presenter: Martin B. Leon, Neil E. Moat, Simon Redwood

October 11, 2015

Presentation TCT 2015

Status Updates on New TAVR Indications 3: Aortic Stenosis + Coronary Artery

Presenter: Martin B. Leon, Neil E. Moat, David Hildick-Smith

October 11, 2015

Presentation TCT 2015

Predicting the Future of Open Surgery for Aortic Stenosis: The TAVR Effect

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

Presentation TCT 2015

Which Aortic Stenosis Patients Are Definitely NOT TAVR Candidates in 2015?

Presenter: Martin B. Leon, Neil E. Moat, Thomas Walther

October 11, 2015

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Aortic Stenosis Use of Advanced Imaging, Hemodynamics, Computational Models, and Clinical Data to Revise Trigger Points for Treatment

Presenter: Eberhard Grube, Michael J. Mack, Elazer R. Edelman

October 11, 2015

Presentation TCT 2015

Hemodynamics of Aortic Stenosis With Gorlin/HAKKI Calculations Using the Telestrator

Presenter: Thomas H. Maloney, Jeff Davis

October 10, 2015

Presentation

30-Day Readmissions After TAVR vs SAVR in Severe Aortic Stenosis Patients in NY State

Presenter: Edward L. Hannan

September 09, 2015

Presentation

Health Status after TAVR or SAVR in Patients with Severe Aortic Stenosis at Increased Surgical Risk

Presenter: Arnold SV.

August 18, 2015

Presentation

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Presenter: CJ. O'Sullivan

August 04, 2015

Presentation SCCT 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presenter: Maros Ferencik

July 18, 2015

Presentation TVT 2015

SAPIEN for Native Mitral Stenosis: Indications, Techniques, and Outcomes

Presenter: Vinayak Bapat, Danny Dvir, Mayra Guerrero

June 05, 2015

Presentation TVT 2015

Multiple Clips: Balancing Stenosis Versus Regurgitation

Presenter: Gorav Ailawadi, Brij Maini, James B. Hermiller Jr.

June 04, 2015

Presentation TVT 2015

Sapien in Native Mitral Stenosis: Feasibility and Registry Results

Presenter: Nicolo Piazza, Gregg W. Stone, Mayra Guerrero

June 04, 2015

Presentation Fellows 2015

Indications and Treatment Options for Aortic Stenosis: Past, Present, and Future

Presenter: Mark Reisman, Nirat Beohar, Tamim Nazif

May 17, 2015

Advertisement

CoreValve US Extreme Risk: Evaluation of a Self-Expanding Transcatheter Aortic Valve in Patients With Severe Aortic Stenosis at Extreme Risk for Surgery

Valvular Heart Disease: Treatment of Mitral Stenosis and Mitral Regurgitation

The United Kingdom Presents: A Case of iFR for Evaluation of Serial Stenosis Using Pullback

How Did I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Would I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

How Should I Treat a High Surgical Risk Patient With Bicuspid Aortic Valve Stenosis?

Status Updates on New TAVR Indications 4: Aortic Stenosis + Mitral Regurgitation

Status Updates on New TAVR Indications 3: Aortic Stenosis + Coronary Artery

Predicting the Future of Open Surgery for Aortic Stenosis: The TAVR Effect

Which Aortic Stenosis Patients Are Definitely NOT TAVR Candidates in 2015?

KEYNOTE LECTURE: Redefining Aortic Stenosis Use of Advanced Imaging, Hemodynamics, Computational Models, and Clinical Data to Revise Trigger Points for Treatment

Hemodynamics of Aortic Stenosis With Gorlin/HAKKI Calculations Using the Telestrator

30-Day Readmissions After TAVR vs SAVR in Severe Aortic Stenosis Patients in NY State

Health Status after TAVR or SAVR in Patients with Severe Aortic Stenosis at Increased Surgical Risk

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

SAPIEN for Native Mitral Stenosis: Indications, Techniques, and Outcomes

Multiple Clips: Balancing Stenosis Versus Regurgitation

Sapien in Native Mitral Stenosis: Feasibility and Registry Results

Indications and Treatment Options for Aortic Stenosis: Past, Present, and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content